Category
Primary
lung-and-respiratory-health · embed-ft 0.22
Tree path
Medical Health › Diseases and Conditions › Lung and Respiratory Health
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Evidence
llms.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
Emphycorp Inc Creating the future of Non-Steroidal Nasal Sprays
Description
EmphyCorp Inc is a Private NJ Biotech focused on Providing Safer Rx Nasal Spray Drugs with no known side effects for the treatment of major Respiratory Diseases and COVID-19, including Pulmonary Fibrosis, Cystic Fibrosis, COPD, Flu, COVID-19, and COVID Long Haulers Treatments.Three Successful Phase III N115 Nasal Spray Clinical Trials were completed for Pulmonary Fibrosis, COVID-19, and COVID-19 Long Haulers (Long COVID) Treatments.A Phase III Clinical Trial for Flu will start soon.In 2021, a ne
Final URL
Language
en (html)
Scanned at
2026-06-21 16:29:04